What Materials Management Audits Cover
Materials management is the system that controls the receipt, storage, sampling, testing, and release of materials used in manufacturing. It is the first line of defense against contamination and mix ups. If materials are not controlled, the product cannot be assured.
A GMP audit for materials management assesses whether materials are received and identified correctly, whether they are stored appropriately, whether sampling and testing are performed, and whether release is controlled. The scope includes receipt, quarantine, storage, sampling, testing, release, and rejection.
The Regulatory Context
FDA 21 CFR 211 Subpart E
The FDA sets requirements for control of components in 21 CFR 211 Subpart E. Materials must be received, identified, stored, sampled, tested, and released.
EU GMP Chapter 4 and Chapter 5
Chapter 4 of EudraLex Volume 4 covers documentation. Chapter 5 covers production, including materials management.
ICH Q7 and Materials Management
ICH Q7 covers materials management for APIs, including receipt, quarantine, sampling, and release.
PIC/S and WHO
PIC/S Guide PE 009 and WHO GMP guidelines cover materials management.
What Audits Focus On
Receipt
Materials should be received and identified. The audit should check that receipt is documented and that materials are checked against specifications.
Quarantine
Materials should be quarantined until released. The audit should check that quarantine is controlled.
Storage
Materials should be stored appropriately. The audit should check that storage conditions are maintained.
Sampling
Sampling should be representative. The audit should check that sampling is documented and controlled.
Testing
Testing should be performed. The audit should check that testing is completed and documented.
Release
Release should be controlled. The audit should check that release is authorized and documented.
Rejection
Rejected materials should be controlled. The audit should check that rejection is documented and that materials are segregated.
Common Findings in Materials Management Audits
Receipt Documentation Gaps
Quarantine Controls That Are Not Followed
Storage Conditions That Are Not Maintained
Sampling That Is Not Representative
Release That Is Not Authorized
Rejection That Is Not Controlled
Introducing GxP Cellators for Materials Management Audits
GxP Cellators provides GMP audits for materials management covering receipt, quarantine, storage, sampling, testing, release, and rejection.
We work across FDA, EMA, Health Canada, MHRA, WHO, and PIC/S frameworks. Our auditors bring regulatory inspection and industry quality experience, and we deliver clear, prioritized reports with practical remediation guidance.
Control Your Materials
Visit https://www.gxpcellators.com/gmp-auditing/ for service details. Email or use https://www.gxpcellators.com/contact/ to discuss your materials management audit.
Frequently Asked Questions About Materials Management Audits
Why is quarantine important?
Quarantine prevents unreleased materials from being used in production.
How should sampling be performed?
Sampling should be representative and should follow a defined plan.
What is release?
Release is the authorization to use a material in production.
Can you help us prepare for an inspection of materials management?
Yes. We conduct readiness reviews and mock inspections.
How do I request a materials management audit?
Email or use https://www.gxpcellators.com/contact/. Service details are at https://www.gxpcellators.com/gmp-auditing/.

